Cdk Inhibitor p27Kip1 and Hormone Dependence in Breast Cancer

Clinical Cancer Research

Volumn 10, Issue 1 II, 2004, Pages

  Arteaga, Carlos L ^a,b   Medina, Daniel ^c   Brown, Myles ^c   Santer, Richard ^c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CYCLIN D; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; METHOTREXATE; PROTEIN P27; TAMOXIFEN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ESTROGEN; TUMOR SUPPRESSOR PROTEIN;

BREAST CANCER; CANCER HORMONE THERAPY; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DOWN REGULATION; DRUG MECHANISM; DRUG SENSITIVITY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; UPREGULATION; ALLELE; ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; CYTOPLASM; CYTOSOL; METABOLISM;

ALLELES; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; CYTOSOL; ESTROGENS; G1 PHASE; HUMANS; MODELS, GENETIC; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 1442357323     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-031204     Document Type: Conference Paper

References (33)

1. Philipp-Staheli, J., Payne, S. R., and Kemp, C. J. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res., 264: 148-168, 2001.
2. Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., and Kemp, C. J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396: 177-180, 1998.
3. Slingerland, J., and Pagano, M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol., 183: 10-17, 2000.
4. Muraoka, R. S., Lenferink, A. E., Simpson, J., Brantley, D. M., Roebuck, L. R., Yakes, F. M., and Arteaga, C. L. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J. Cell Biol., 153: 917-932, 2001.
5. Muraoka, R. S., Lenferink, A. E., Law, B., Hamilton, E., Brantley, D. M., Roebuck, L. R., and Arteaga, C. L. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Mol. Cell Biol., 22: 2204-2219, 2002.
6. Cheng, M., Sexl, V., Sherr, C. J., and Roussel, M. F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA, 95: 1091-1096, 1998.
7. Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo. J., 18: 1571-1583, 1999.
8. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
9. Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K. I., and Slingerland, J. M. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227-230, 1997.
10. Tan, P., Cady, B., Wanner, M., Worland, P., Cukor, B., Magi-Galluzzi, C., Lavin, P., Draetta, G., Pagano, M., and Loda, M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57: 1259-1263, 1997.
11. Loden, M., Nielsen, N. H., Roos, G., Emdin, S. O., and Landberg, G. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation. Oncogene, 18: 2557-2566, 1999.
12. Newman, L., Xia, W., Yang, H. Y., Sahin, A., Bondy, M., Lukmanji, F., Hung, M. C., and Lee, M. H. Correlation of p27 protein expression with HER-2/ neu expression in breast cancer. Mol. Carcinog., 30: 169-175, 2001.
13. Chappuis, P. O., Kapusta, L., Begin, L. R., Wong, N., Brunet, J. S., Narod, S. A., Slingerland, J., and Foulkes, W. D. Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. J. Clin. Oncol., 18: 4045-4052, 2000.
14. Lenferink, A. E., Busse, D., Flanagan, W. M., Yakes, F. M., and Arteaga, C. L. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Cancer Res., 61: 6583-6591, 2001.
15. Yang, H. Y., Zhou, B. P., Hung, M. C., and Lee, M. H. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem., 275: 24735-24739, 2000.
16. Lane, H. A., Beuvink, I., Motoyama, A. B., Daly, J. M., Neve, R. M., and Hynes, N. E. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Mol. Cell Biol., 20: 3210-3223, 2000.
17. Perez-Roger, I., Kim, S. H., Griffiths, B., Sewing, A., and Land, H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). Embo. J., 18: 5310-5320, 1999.
18. Aktas, H., Cai, H., and Cooper, G. M. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell Biol., 17: 3850-3857, 1997.
19. Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S., and Uehara, Y. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene, 15: 629-637, 1997.
20. Shin, I., Yakes, F. M., Rojo, F., Shin, N. Y., Bakin, A. V., Baselga, J., and Arteaga, C. L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med., 8: 1145-1152, 2002.
21. Viglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., Fusco, A., and Santoro, M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med., 8: 1136-1144, 2002.
22. Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J. H., Ciarallo, S., Catzavelos, C., Beniston, R., Franssen, E., and Slingerland, J. M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med., 8: 1153-1160, 2002.
23. Rodier, G., Montagnoli, A., Di Marcotullio, L., Coulombe, P., Draetta, G. F., Pagano, M., and Meloche, S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. Embo. J., 20: 6672-6682, 2001.
24. Boehm, M., Yoshimoto, T., Crook, M. F., Nallamshetty, S., True, A., Nabel, G. J., and Nabel, E. G. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. Embo. J., 21: 3390-3401, 2002.
25. Orend, G., Hunter, T., and Ruoslahti, E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene, 16: 2575-2583, 1998.
26. Singh, S. P., Lipman, J., Goldman, H., Ellis, F. H., Jr., Aizenman, L., Cangi, M. G., Signoretti, S., Chiaur, D. S., Pagano, M., and Loda, M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res., 58: 1730-1735, 1998.
27. Ciaparrone, M., Yamamoto, H., Yao, Y., Sgambato, A., Cattoretti, G., Tomita, N., Monden, T., Rotterdam, H., and Weinstein, I. B. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res., 58: 114-122, 1998.
28. McAllister, S. S., Becker-Hapak, M., Pintucci, G., Pagano, M., and Dowdy, S. F. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol. Cell Biol., 23: 216-228, 2003.
29. Cariou, S., Donovan, J. C., Flanagan, W. M., Milic, A., Bhattacharya, N., and Slingerland, J. M. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc. Natl. Acad. Sci. USA, 97: 9042-9046, 2000.
30. Donovan, J. C., Milic, A., and Slingerland, J. M. Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells. J. Biol. Chem., 276: 40888-40895, 2001.
31. Pohl, G., Rudas, M., Dietze, O., Lax, S., Markis, E., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., Samonigg, H., Jakesz, R., and Filipits, M. High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin. J. Clin. Oncol., 21: 3594-3600, 2003.
32. Tsihlias, J., Kapusta, L. R., DeBoer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Catzavelos, G. C., Klotz, L. H., and Slingerland, J. M. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58: 542-548, 1998.
33. Yang, R. M., Naitoh, J., Murphy, M., Wang, H. J., Phillipson, J., deKernion, J. B., Loda, M., and Reiter, R. E. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol., 159: 941-945, 1998.